Skip to main content
Top
Published in: Internal and Emergency Medicine 8/2022

29-07-2022 | COVID-19 | IM - ORIGINAL

Relationship between the severity of persistent symptoms, physical fitness, and cardiopulmonary function in post-COVID-19 condition. A population-based analysis

Authors: Amaya Jimeno-Almazán, Alejandro Martínez-Cava, Ángel Buendía-Romero, Francisco Franco-López, José Antonio Sánchez-Agar, Bernardino Javier Sánchez-Alcaraz, James J. Tufano, Jesús G. Pallarés, Javier Courel-Ibáñez

Published in: Internal and Emergency Medicine | Issue 8/2022

Login to get access

Abstract

The aim of this study was to determine the relationship between physical fitness, cardiopulmonary function and patient-reported severity of symptoms in people with post-COVID-19 condition. We examined ambulatory patients (n = 72) with post-COVID-19 condition who had a chronic symptomatic phase lasting > 12 weeks from the onset of symptoms, but had not been hospitalized for acute COVID-19. A comprehensive medical screening was conducted, including clinical history, symptomatology, comorbidities, body composition and physical activity levels. We then identified the relationship between physical fitness (cardiorespiratory fitness and muscular strength), cardiopulmonary function (echocardiographic and spirometry parameters) and patient-reported severity of symptoms (fatigue, dyspnea, health-related quality of life, anxiety, and depression). Age, body mass index, sex, number of comorbidities and duration of symptoms were included as potential confounders. Results showed that greater physical fitness and cardiopulmonary function were associated with lower severity of symptoms in people with post-COVID-19 condition. Cardiorespiratory fitness, lower-limb muscle strength, maximal voluntary ventilation and left ventricular ejection fraction account for reducing fatigue and dyspnea. Greater physical activity levels were associated with fewer symptoms and less-severe fatigue and dyspnea. In conclusion, preserving better cardiopulmonary health and physical condition during the course of the disease—even in mild cases—was related to a lower intensity of symptoms in non-hospitalized people with post-COVID-19 condition. It is probable that exercise and physical conditioning are valuable pre- and post-COVID-19 countermeasures that could help decrease the severity, not only of acute infection, but of post-COVID-19 persistent symptoms and prognosis.
Literature
1.
go back to reference WHO Headquarters (HQ) (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus WHO Headquarters (HQ) (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus
11.
go back to reference Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á et al (2021) Post-covid-19 syndrome and the potential benefits of exercise. Int J Environ Res Public Health 18:5329CrossRefPubMedPubMedCentral Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á et al (2021) Post-covid-19 syndrome and the potential benefits of exercise. Int J Environ Res Public Health 18:5329CrossRefPubMedPubMedCentral
Metadata
Title
Relationship between the severity of persistent symptoms, physical fitness, and cardiopulmonary function in post-COVID-19 condition. A population-based analysis
Authors
Amaya Jimeno-Almazán
Alejandro Martínez-Cava
Ángel Buendía-Romero
Francisco Franco-López
José Antonio Sánchez-Agar
Bernardino Javier Sánchez-Alcaraz
James J. Tufano
Jesús G. Pallarés
Javier Courel-Ibáñez
Publication date
29-07-2022
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 8/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-022-03039-0

Other articles of this Issue 8/2022

Internal and Emergency Medicine 8/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.